[1]
T. S. Brytanova, “In silico study of potential bacterial peptide deformylase inhibitors among 4-((furan-2-ylmethyl)amino)-3,5-dimethyl-1-(2-aryl-2-oxoethyl)-1,2,4-triazolium bromides”, Current issues in pharmacy and medicine: science and practice, vol. 19, no. 1, pp. 36–42, Mar. 2026.